QuidelOrtho to Report 3Q 2024 Financial Results
October 18, 2024
October 18, 2024
SAN DIEGO, California, Oct. 18 -- Quidel Corp., a provider of in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, issued the following news release on Oct. 17, 2024:
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will . . .
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will . . .